Safety and Efficacy of ENV515 Travoprost Extended Release (XR) in Patients With Bilateral Ocular Hypertension or Primary Open Angle Glaucoma
Clinical trial NCT02371746 · COMPLETED
Trial details
- NCT number
- NCT02371746
- Sponsor
- Envisia Therapeutics
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-01
- Primary completion
- 2019-02-13
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.